Drug Pipeline News

>

Latest News

FDA-approved berdazimer gel, 10.3% launches to treat molluscum contagiosum | Image Credit: © syahrir - ©syahrir - stock.adobe.com.
FDA-approved berdazimer gel, 10.3% launches to treat molluscum contagiosum

July 10th 2025

The nitric oxide–releasing topical is the first prescription medication approved for at-home treatment of molluscum contagiosum.

FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency | © Contemporary Pediatrics
FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency

July 8th 2025

FDA approves sebetralstat as first and only on-demand treatment for HAE | Image Credit: Contemporary Pediatrics
FDA approves sebetralstat as first and only on-demand treatment for HAE

July 7th 2025

Key FDA approvals in pediatric health: First half of 2025 | Image Credit: © Postmodern Studio - stock.adobe.com.
Key FDA approvals in pediatric health: First half of 2025

July 5th 2025

© Contemporary Pediatrics
FDA news in pediatrics: June 2025

July 1st 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.